These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24778448)

  • 1. Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.
    O'Brien S; Thomas RM; Wertheim GB; Zhang F; Shen H; Wells AD
    J Immunol; 2014 Jun; 192(11):5118-29. PubMed ID: 24778448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function.
    Curtsinger JM; Agarwal P; Lins DC; Mescher MF
    J Immunol; 2012 Jul; 189(2):659-68. PubMed ID: 22706089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes.
    Thomas RM; Chunder N; Chen C; Umetsu SE; Winandy S; Wells AD
    J Immunol; 2007 Dec; 179(11):7305-15. PubMed ID: 18025173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.
    Northrop JK; Thomas RM; Wells AD; Shen H
    J Immunol; 2006 Jul; 177(2):1062-9. PubMed ID: 16818762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells.
    Feau S; Arens R; Togher S; Schoenberger SP
    Nat Immunol; 2011 Jul; 12(9):908-13. PubMed ID: 21804558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
    Sad S; Mosmann TR
    J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
    Urban JA; Winandy S
    J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells.
    Orgun NN; Mathis MA; Wilson CB; Way SS
    J Immunol; 2008 Mar; 180(6):4109-15. PubMed ID: 18322221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 and autocrine IL-4 drive the in vivo development of antigen-specific Th2 T cells elicited by nematode parasites.
    Liu Z; Liu Q; Hamed H; Anthony RM; Foster A; Finkelman FD; Urban JF; Gause WC
    J Immunol; 2005 Feb; 174(4):2242-9. PubMed ID: 15699158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
    Kim S; Shen T; Min B
    J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production.
    Ertelt JM; Johanns TM; Rowe JH; Way SS
    Immunology; 2010 Oct; 131(2):183-91. PubMed ID: 20465570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection.
    Way SS; Havenar-Daughton C; Kolumam GA; Orgun NN; Murali-Krishna K
    J Immunol; 2007 Apr; 178(7):4498-505. PubMed ID: 17372008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
    Selvan RS; Nagarkatti PS; Nagarkatti M
    Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).
    Tham EL; Mescher MF
    J Immunol; 2002 Aug; 169(4):1822-8. PubMed ID: 12165505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
    Croft M; Carter L; Swain SL; Dutton RW
    J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: Ikaros is a regulator of Th2 cell differentiation.
    Quirion MR; Gregory GD; Umetsu SE; Winandy S; Brown MA
    J Immunol; 2009 Jan; 182(2):741-5. PubMed ID: 19124715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of IκB
    Frentzel S; Katsoulis-Dimitriou K; Jeron A; Schmitz I; Bruder D
    Eur J Immunol; 2019 Sep; 49(9):1391-1398. PubMed ID: 31049948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.